Company overview
Quantum-Si offers benchtop proteomics platforms for single-molecule protein sequencing, enabling real-time analysis in research labs. Their Platinum and upcoming Proteus systems provide next-generation performance for biomarker discovery and therapeutic development. Key advancements include detection of up to 20 amino acids and controlled cleavage chemistry for billions of sequencing reads.
Single-Molecule Protein Sequencing Solutions is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, Diagnostics & Testing partner serving United States & Americas. Core focus areas include protein sequencing, proteomics platform, single-molecule detection, benchtop sequencer, quantum-si proteus.
Industry categories: Life Science Reagents, Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.quantum-si.com
- Categories
- Life Science Reagents, Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- protein sequencing, proteomics platform, single-molecule detection, benchtop sequencer, quantum-si proteus
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What protein sequencing platforms does Quantum-Si offer?
- Quantum-Si provides the Platinum Pro benchtop platform for single-molecule protein sequencing, with the Proteus platform on track for launch by end of 2026, offering improved amino acid coverage and sequencing performance.
- What are the key capabilities of Quantum-Si's technology?
- The platforms enable real-time, single-molecule detection of amino acids including glycine, methionine, and sequencing through proline-rich regions, with Proteus expected to cover 18 amino acids at launch and all 20 by 2027, plus PTM analysis.
- What is the timeline for Quantum-Si's Proteus platform?
- Proteus early access starts summer 2026, with full launch by end of 2026; pricing announced Q2 2026, launch capabilities Q3 2026, and Platinum Pro upgrade program Q3 2026.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
